Development of the Reactive Aggression Assessment (RAGA-16) Part II: Clinical Validation.

IF 5.2 1区心理学 Q1 PSYCHOLOGY, CLINICAL

Journal of Clinical Child and Adolescent Psychology Pub Date : 2026-07-17 DOI:10.1080/15374416.2026.2697487

Joshua Langfus, Robert L Findling, Evangelia Fatourou, Kelsey Delph, Sebastian Nair, Joe Quesenberry, Ekaterina Stepanova, Eric A Youngstrom

{"title":"Development of the Reactive Aggression Assessment (RAGA-16) Part II: Clinical Validation.","authors":"Joshua Langfus, Robert L Findling, Evangelia Fatourou, Kelsey Delph, Sebastian Nair, Joe Quesenberry, Ekaterina Stepanova, Eric A Youngstrom","doi":"10.1080/15374416.2026.2697487","DOIUrl":null,"url":null,"abstract":"Objective: Reactive aggression (RA) is a transdiagnostic symptom associated with more severe illness and worse clinical course. Despite the clinical importance of RA, few validated screening measures or outcome assessments exist for use with children under 12. The 16-item Reactive Aggression Assessment (RAGA-16) is a novel parent-report instrument with promising evidence of psychometric reliability. The current work presents clinical validation evidence for RAGA-16.Methods: A retrospective chart review examined the records of children seeking inpatient and outpatient services. Parents completed the RAGA-16 and additional questionnaires assessing depression, hypomania, ADHD symptoms, and aggression at intake. The chart review also included clinical diagnoses, demographic information, and treatment details. Graded response models (GRMs) evaluated the RAGA-16 factor structure and associations with criterion variables evaluated the scores' validity as a screening measure assessing RA.Results: Confirmatory models showed good fit to the hypothesized two-factor structure with high marginal reliability (ωt = .98). RAGA-16 scores showed large significant positive associations with measures of aggression, impulsivity, and oppositionality (rs > .70, ps < .001), lower associations with hypomanic symptoms (r = .40, p < .01), and no significant association with depression (p > .05). RAGA-16 scores statistically discriminated diagnoses associated with severely externalizing symptoms from other diagnoses. Endorsement of RA in more contexts (home, school, or elsewhere) was associated with higher aggression symptoms.Conclusions: Overall, RAGA-16 scores showed a pattern of criterion associations consistent with the construct of interest along with high score reliability. The addition of inpatient and outpatient clinical score characteristics to the existing epidemiological norms makes RAGA-16 a promising new tool for assessing youth RA.","PeriodicalId":48350,"journal":{"name":"Journal of Clinical Child and Adolescent Psychology","volume":" ","pages":"1-20"},"PeriodicalIF":5.2000,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Child and Adolescent Psychology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/15374416.2026.2697487","RegionNum":1,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Reactive aggression (RA) is a transdiagnostic symptom associated with more severe illness and worse clinical course. Despite the clinical importance of RA, few validated screening measures or outcome assessments exist for use with children under 12. The 16-item Reactive Aggression Assessment (RAGA-16) is a novel parent-report instrument with promising evidence of psychometric reliability. The current work presents clinical validation evidence for RAGA-16.

Methods: A retrospective chart review examined the records of children seeking inpatient and outpatient services. Parents completed the RAGA-16 and additional questionnaires assessing depression, hypomania, ADHD symptoms, and aggression at intake. The chart review also included clinical diagnoses, demographic information, and treatment details. Graded response models (GRMs) evaluated the RAGA-16 factor structure and associations with criterion variables evaluated the scores' validity as a screening measure assessing RA.

Results: Confirmatory models showed good fit to the hypothesized two-factor structure with high marginal reliability (ωt = .98). RAGA-16 scores showed large significant positive associations with measures of aggression, impulsivity, and oppositionality (rs > .70, ps < .001), lower associations with hypomanic symptoms (r = .40, p < .01), and no significant association with depression (p > .05). RAGA-16 scores statistically discriminated diagnoses associated with severely externalizing symptoms from other diagnoses. Endorsement of RA in more contexts (home, school, or elsewhere) was associated with higher aggression symptoms.

Conclusions: Overall, RAGA-16 scores showed a pattern of criterion associations consistent with the construct of interest along with high score reliability. The addition of inpatient and outpatient clinical score characteristics to the existing epidemiological norms makes RAGA-16 a promising new tool for assessing youth RA.

查看原文本刊更多论文

反应性攻击评估的发展（RAGA-16）第二部分：临床验证。

目的：反应性攻击（Reactive aggression， RA）是一种病情较重、临床病程较差的跨诊断症状。尽管RA具有重要的临床意义，但很少有有效的筛查措施或用于12岁以下儿童的结果评估。反应性攻击量表（RAGA-16）是一种新型的父母报告量表，具有良好的心理测量信度证据。目前的工作提供了RAGA-16的临床验证证据。方法：回顾性分析儿童住院和门诊记录。家长们完成了RAGA-16和额外的问卷调查，评估抑郁、轻躁狂、多动症症状和摄入时的攻击性。图表回顾还包括临床诊断、人口统计信息和治疗细节。分级反应模型（GRMs）评估RAGA-16因子结构，与标准变量的关联评估评分作为评估RA的筛选措施的有效性。结果：验证模型与假设的双因素结构拟合良好，具有较高的边际信度（ωt = 0.98）。RAGA-16得分与攻击性、冲动性和对立性表现出显著正相关。70, ps r = 0.40, p p r = 0.05)。RAGA-16评分在统计上区分了与其他诊断的严重外化症状相关的诊断。在更多的环境中（家庭、学校或其他地方），RA的认可与更高的攻击症状相关。结论：总体而言，RAGA-16分数显示出与兴趣结构一致的标准关联模式以及高分数信度。将住院和门诊临床评分特征添加到现有的流行病学规范中，使RAGA-16成为评估青少年RA的有希望的新工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Child and Adolescent Psychology Multiple-

CiteScore

9.70

自引率

4.80%

发文量

期刊介绍： The Journal of Clinical Child and Adolescent Psychology (JCCAP) is the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association. It publishes original contributions on the following topics: (a) the development and evaluation of assessment and intervention techniques for use with clinical child and adolescent populations; (b) the development and maintenance of clinical child and adolescent problems; (c) cross-cultural and sociodemographic issues that have a clear bearing on clinical child and adolescent psychology in terms of theory, research, or practice; and (d) training and professional practice in clinical child and adolescent psychology, as well as child advocacy.